Javascript on your browser is not enabled.


Dabur Promoter’s ‘HealthCare atHOME’ to Expand its Services Pan India by End of 2017

The Burman family of Dabur fame is going into tech driven healthcare services from their days promoting traditional Ayurvedic treatments

Vivek Srivastava, CEO and cofounder of Healthcare atHome
The Burman family now promotes tech driven healthcare

HealthCare atHOME, India’s leading provider of technology-driven home-based medical services, is all set to expand its footprint in all metro cities pan India by the end of 2017. Started by Dabur India’s promoter Burman family and founders of UK-based Healthcare at Home (HAH), the Indian unit will soon start its services in Hyderabad, the joint capital city of Andhra Pradesh and Telangana.

At present, they are funded completely by the Burman family and founders of HAH (UK). 

Vivek Srivastava, CEO and cofounder of Healthcare atHome says, “At present, HealthCare atHOME services are available in Delhi/NCR, Mumbai, Punjab, Jaipur, Bengaluru, Pune, Indore and in a few more cities. Around 2000 personnel will be hired by the company by the end of the year to meet expansion requirements. HealthCare atHOME is working with a team of 800 staff personnel in over 30 cities in the B2B segment, 6 cities in the B2C segment and 12 cities in the pharmacy segment”.

The overall Indian healthcare market today is worth rupees 6.7 lakh crore and is expected to grow to rupees 18.7 lakh crore by 2020. Globally, home healthcare segment comprises of 3-6% of the total healthcare market and Indian home healthcare market which can reach rupees 10 lakh crore by 2020.

According to World Health Statistics (2015), India needs to add at least 650,000 beds by 2017, requiring a capital investment of rupees 1.6 lakh crore. Home healthcare has the potential to transform the healthcare delivery segment in India. It reduces the pressure of hospital infrastructure, ensures a smooth transition from hospital to home, and even reduces the chances of re-admissions. The facility is giving quality healthcare in Tier I and Tier II cities and also reducing the treatment cost of the patients.

HealthCare atHOME have conducted more than 1000 chemotherapies/immunotherapies at home and have looked after more than 300,000 patients across the country and that too with a high customer satisfaction rate (Net Promoter Score -NPS >70%) since 2012. They have a repeat rate of more than 50%, a testament to the fact that people who take this service find it valuable enough to continue with it.

The company was started with a corpus of rupees 200 crore and is set to achieve break even over a couple of years. While the CEO of HealthCare atHome said in February this year that there were no plans to raise external funding, the company announced 40 million dollars from Quadria Capital in April 2017.

Tags assigned to this article:
dabur Burman Healthcare atHOME Vivek Srivastava

Around The World